Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Journal of Health and Medical Sciences
Volumen 6, Fascículo 1, 2020
Artículo de Investigación
Detección del Síndrome de Morris con técnica imagenológica híbrida. Reporte de Casos

Carlos Alejandro Regalado Alvarado1; Ena María Coloma Coloma2 & Ivanna Noemí Jaramillo Encalada3

  1. Médico Tratante de Medicina Nuclear. Instituto Oncológico Dr. Juan Tanca Marengo SOLCA-Guayaquil, Ecuador.
  2. Médico residente de Medicina Interna. Instituto Oncológico Dr Juan Tanca Marengo SOLCA Guayaquil, Ecuador.
  3. Médico residente de Endocrinología. Hospital Abel Gilbert Ponton, Guayaquil, Ecuador.

La correspondencia debe dirigirse a Carlos Regalado Alvarado. Email:

Recibido el 20 de Octubre del 2019. Aceptado el 05 de Enero de 2020

REGALADO, C.; COLOMA, E. & JARAMILLO, I. Detection of the Morris syndrome with a hybrid imaging technique. Case report. J. Health med. sci., 6(1):17-20, 2020.

ABSTRACT: Morris Syndrome is a recessive genetic disorder linked to the X chromosome. It is characterized by a feminine phenotype and 46 XY karyotype. Gonads can be localized at the upper lips and the inguinal or intra-abdominal canal. In cases where the localization can be at the inguinal conduct or upper lips, gonads are mistaken for hernias and they are removed in childhood; when they are intra-abdominal, approximately 30% has risks of developing gonadal tumors at adulthood, so is necessary its surgical removal. Their localization can be made by ultrasound scans, tomography or magnetic resonance, but sometimes is not possible to identify these structures, so this is where we propose 18-Fluorodeoxyglucose positron emission tomography as a diagnostic tool to localize the gonadal tissue, exploiting the physiological capture of this radiotracer at the testicular tissue.

KEY WORDS: Morris syndrome, feminine phenotype, inguinal canal, intra-abdominal canal.

Dirección para correspondencia:

Carlos Alejandro Regalado Alvarado

Médico Tratante de Medicina Nuclear

Instituto Oncológico Dr. Juan Tanca Marengo




Comunicate con nosotros